Literature DB >> 10448134

RAG and RAG defects.

L D Notarangelo1, A Villa, K Schwarz.   

Abstract

Products of the recombination-activating gene (RAG) play a crucial role in lymphoid cell development. During the past year, the functional properties of RAG protein domains have been better defined. Some mutations that alter the amino acid sequence of RAG1 or RAG2 have been shown to disturb B cell generation and to partially disturb T cell generation, resulting in Omenn syndrome in humans; moreover, peripheral re-expression of RAGs indicates their role in lymphoid cell homeostasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448134     DOI: 10.1016/S0952-7915(99)80073-9

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  10 in total

Review 1.  The RAG proteins in V(D)J recombination: more than just a nuclease.

Authors:  M J Sadofsky
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

2.  An unusual concurrence of graft versus host disease caused by engraftment of maternal lymphocytes with DiGeorge anomaly.

Authors:  J G Ocejo-Vinyals; M J Lozano; P Sánchez-Velasco; J Escribano de Diego; J E Paz-Miguel; F Leyva-Cobián
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

3.  Lessons in gene hunting: a RAG1 mutation presenting with agammaglobulinemia and absence of B cells.

Authors:  Mona Hedayat; Michel J Massaad; Yu Nee Lee; Mary Ellen Conley; Jordan S Orange; Toshiro K Ohsumi; Waleed Al-Herz; Luigi D Notarangelo; Raif S Geha; Janet Chou
Journal:  J Allergy Clin Immunol       Date:  2014-06-27       Impact factor: 10.793

4.  Severe combined immunodeficiency in Serbia and Montenegro between years 1986 and 2010: a single-center experience.

Authors:  Srdjan Pasic; Dragana Vujic; Dobrila Veljković; Bojana Slavkovic; Marija Mostarica-Stojkovic; Predrag Minic; Aleksandra Minic; Goran Ristic; Silvia Giliani; Anna Villa; Cristina Sobacchi; Desa Lilić; Mario Abinun
Journal:  J Clin Immunol       Date:  2014-02-01       Impact factor: 8.317

5.  EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination?

Authors:  Robert A Fenstermaker; Michael J Ciesielski
Journal:  Curr Genomics       Date:  2007-05       Impact factor: 2.236

6.  Mutations in conserved regions of the predicted RAG2 kelch repeats block initiation of V(D)J recombination and result in primary immunodeficiencies.

Authors:  C A Gomez; L M Ptaszek; A Villa; F Bozzi; C Sobacchi; E G Brooks; L D Notarangelo; E Spanopoulou; Z Q Pan; P Vezzoni; P Cortes; S Santagata
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

7.  Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes.

Authors:  M A Curotto de Lafaille; S Muriglan; M J Sunshine; Y Lei; N Kutchukhidze; G C Furtado; A K Wensky; D Olivares-Villagómez; J J Lafaille
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

8.  Collaboration of RAG2 with RAG1-like proteins during the evolution of V(D)J recombination.

Authors:  Lina Marcela Carmona; Sebastian D Fugmann; David G Schatz
Journal:  Genes Dev       Date:  2016-04-07       Impact factor: 11.361

9.  Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model.

Authors:  Marjolein W J Wentink; Tomas Kalina; Martin Perez-Andres; Lucia Del Pino Molina; Hanna IJspeert; François G Kavelaars; Arjan C Lankester; Quentin Lecrevisse; Jacques J M van Dongen; Alberto Orfao; Mirjam van der Burg
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

10.  Zinc-finger nuclease mediated disruption of Rag1 in the LEW/Ztm rat.

Authors:  Nils-Holger Zschemisch; Silke Glage; Dirk Wedekind; Edward J Weinstein; Xiaoxia Cui; Martina Dorsch; Hans-Jürgen Hedrich
Journal:  BMC Immunol       Date:  2012-11-08       Impact factor: 3.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.